Halozyme Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $47M | 981k | 47.81 |
| 2024-09-30 | $57M | 989k | 57.24 |
| 2024-06-30 | $62M | 1.2M | 52.36 |
| 2024-03-31 | $49M | 1.2M | 40.68 |
| 2023-12-31 | $48M | 1.3M | 36.96 |
| 2023-09-30 | $50M | 1.3M | 38.20 |
| 2023-06-30 | $48M | 1.3M | 36.07 |
| 2023-03-31 | $53M | 1.4M | 38.19 |
| 2022-12-31 | $82M | 1.4M | 56.90 |
| 2022-09-30 | $61M | 1.5M | 39.89 |
| 2022-06-30 | $68M | 1.5M | 44.04 |
| 2022-03-31 | $61M | 1.5M | 39.87 |
| 2021-12-31 | $66M | 1.5M | 42.86 |
| 2021-09-30 | $64M | 1.6M | 40.70 |
| 2021-06-30 | $67M | 1.5M | 45.54 |
| 2021-03-31 | $60M | 1.4M | 41.42 |
| 2020-12-31 | $63M | 1.5M | 42.85 |
| 2020-09-30 | $19M | 719k | 26.28 |
| 2020-06-30 | $19M | 696k | 26.85 |
| 2020-03-31 | $11M | 623k | 17.99 |
| 2019-12-31 | $11M | 645k | 17.73 |
| 2019-09-30 | $10M | 644k | 15.51 |
| 2019-06-30 | $11M | 661k | 17.18 |
| 2019-03-31 | $10M | 642k | 16.10 |
| 2018-12-31 | $9.7M | 662k | 14.63 |
| 2018-09-30 | $31M | 1.7M | 18.17 |
| 2018-06-30 | $29M | 1.7M | 16.87 |
| 2018-03-31 | $34M | 1.7M | 19.59 |
| 2017-12-31 | $38M | 1.9M | 20.26 |
| 2017-06-30 | $24M | 1.9M | 12.82 |
| 2017-03-31 | $23M | 1.8M | 12.96 |
| 2016-12-31 | $14M | 1.4M | 9.88 |
| 2016-09-30 | $21M | 1.7M | 12.08 |
| 2016-06-30 | $20M | 2.3M | 8.63 |